1-8 of 8
Marc E. Rothenberg, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Spi-C Negatively Regulates Murine Eosinophil Differentiation

Kaila L Schollaert, MA, Michael R Stephens, Melissa K. Mingler, MBA, Marc E. Rothenberg, MD, PhD, Patricia C. Fulkerson, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2273.
https://doi.org/10.1182/blood.V122.21.2273.2273
Published: 2013
Journal Articles

Negative Regulation of Eosinophil Production by Toll-Like Receptors

Kaila L. Schollaert, MS, Melissa K. Mingler, MBA, Marc E. Rothenberg, MD, PhD, Patricia C. Fulkerson, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1237.
https://doi.org/10.1182/blood.V120.21.1237.1237
Published: 2012
Journal Articles

Toll-Like Receptor Signaling Inhibits Eosinophilopoiesis.

Patricia C Fulkerson, MD, PhD, Kaila L Schollaert, MS, H. Leighton Grimes, PhD, Marc E Rothenberg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1558.
https://doi.org/10.1182/blood.V116.21.1558.1558
Published: 2010
Journal Articles

Stem Cell Factor Signaling Collaborates in the Development of FIP1L1/PDGFRα Induced Chronic Eosinophilic Leukemia in a Murine Model

Yoshiyuki Yamada, MD, PhD, Marc E Rothenberg, MD, PhD, Melissa McBride, Abel Sanchez-Aguilera, PhD, Jose Cancelas, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 470.
https://doi.org/10.1182/blood.V112.11.470.470
Published: 2008
Journal Articles

FIP1L1/PDGFRa Synergizes with SCF/c-Kit Signaling To Induce Systemic Mastocytosis in a Chronic Eosinophilic Leukemia Murine Model

Yoshiyuki Yamada, MD, PhD, Jose A. Cancelas, MD, PhD, Eric B. Brandt, PhD, Abel Sanchez-Aguilera, PhD, Melissa McBride, BS, Nabel J.H. Al-Moamen, BS, Fred Finkelman, MD, David A. Williams, MD, Marc E. Rothenberg, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1540.
https://doi.org/10.1182/blood.V110.11.1540.1540
Published: 2007
Journal Articles

Steroid-Sparing Effects of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Marc E. Rothenberg, MD, PhD, Gerald J. Gleich, MD, Florence E. Roufosse, MD, Lanny J. Rosenwasser, MD, Peter F. Weller, MD
Journal: Blood
Blood (2006) 108 (11): 373.
https://doi.org/10.1182/blood.V108.11.373.373
Published: 2006
Journal Articles

SCF and IL-5 Synergize with FIP1L1/PDGFRα To Induce Mastocytosis in a Chronic Eosinophilic Leukemia Murine Model.

Yoshiyuki Yamada, MD, PhD, Marc E. Rothenberg, MD, PhD, Andrew W. Lee, BS, Nabeel J.H. Al-Moamen, BS, David A. Williams, MD, Jose A. Cancelas, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3631.
https://doi.org/10.1182/blood.V108.11.3631.3631
Published: 2006
Journal Articles

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Amy D. Klion, MD, Marc E. Rothenberg, MD, PhD, John J. Murray, MD,PhD, Anish Singh, MD, PhD, Hans-Uwe Simon, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2694.
https://doi.org/10.1182/blood.V108.11.2694.2694
Published: 2006